Quality control in toxicological analysis

Journal of Chromatography B: Biomedical Applications

Volumn 713, Issue 1, 1998, Pages 227-243

  Ferrara, Davide S ^a   Tedeschi, Luciano ^a   Frison, Giampietro ^a   Brusini, Gianpaolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Drugs of abuse; Proficiency testing program; Quality control; Review

Indexed keywords

AMPHETAMINE; AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABINOID; CHLORPROMAZINE; COCAINE; EPHEDRINE; ETHYLMORPHINE; METHADONE; OPIATE DERIVATIVE; PHENTERMINE; PHENYLPROPANOLAMINE; SELEGILINE;

ANALYTIC METHOD; ANALYTICAL ERROR; DRUG DETERMINATION; HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; REVIEW; SCREENING TEST; TOXICOLOGY;

HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; QUALITY CONTROL; REFERENCE STANDARDS; REFERENCE VALUES; TERMINOLOGY; TOXICOLOGY;

EID: 0032555717     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(98)00010-3     Document Type: Review

References (73)

1. A. Cross-Smiecinski, L.D. Stetzenbach, Quality Planning for the Life Science Researcher, CRC Press, Boca Raton, FL, 1994.
2. Bachner P. Clin. Lab. Med. 6:1986;613.
3. Mesley R.J., Pocklington W.D., Walker R.F. Analyst. 116:1991;975.
4. Revisions of the Laboratory Regulations for the Medicare, Medicaid, and Clinical Laboratory Improvement Act of 1967: Final Rule with Comment Period, USA Federal Register, March 14, 55 (1990) 9538.
5. International Organization for Standardization, General Requirements for the Competence of Calibration and Testing Laboratories, ISO Guide 25, 3rd ed., Geneva, 1990.
6. The Joint European Standards Institution, General Criteria for the Operation of Testing Laboratories, EN 45001, CEN/Cenelec, Brussels, 1989.
7. Hyltoft Petersen P., Ricos C., Stockl D., Libeer J.C., Baadenhujisen H., Fraser C., Thienpont L. Eur. J. Clin. Chem. Clin. Biochem. 34:1996;983.
8. Blanke R. Clin. Chem. 33:1987;41B.
9. de la Torre R., Segura J., de Zeeuw R.A., Williams J. In collaboration with the Toxicology Experts Working Group. Ann. Clin. Biochem. 34:1997;339.
10. NIDA, Technical, Scientific and Procedural Issues of Employee Drug Testing - Consensus Report, DHHS Publication, Rockville, 1990.
11. Libeer J.C., Baadenhujisen H., Fraser C.G., Hyltoft Petersen P., Stockl D., Ricos C., Thienpont L. Eur. J. Clin. Chem. Clin. Biochem. 34:1996;665.
12. Hyltoft Petersen P., Blaabjerg O., Irjala K., Icen A., Bjoro K. Uppsala J. Med. Sci. 98(C.H. deVerdieer, T. Groth, P. Hyltoft Petersen (Eds.), Medical Need for Quality Specifications in Clinical Laboratories):1993;241.
13. Analytical Methods Committee, Analyst. 114:1989;1497.
14. R.S. Galen, S.R. Gambino, Beyond Normality: the Predictive Value and the Efficiency of Medical Diagnoses, Wiley & Sons, New York, 1975.
15. Griner P.F., Mayewski R.J., Mushlin A.I., Greenland P. Ann. Intern. Med. 94:1981;553.
16. S.K. Lwanga, C.Y. Tye, Teaching Health Statistics, World Health Organization, Geneva, 1986, p. 69.
17. Spiehler V.R., O'Donnell C.M., Gokhale D.V. Clin. Chem. 34:1988;1535.
18. Ferrara S.D., Tedeschi L., Frison G., Brusini G., Castagna F., Bernardelli B., Soregaroli D. J. Anal. Toxicol. 18:1994;278.
19. Westgard J.O., Quam E.F., Barry P.L. Clin. Lab. Sci. 3:1990;273.
20. Westgard J.O. Med. Lab. Observ. 26:1994;55.
21. W.A. Shewhart, Economic Control of the Quality of Manufactured Products, McMillan, London, 1931.
22. Levey S., Jenning E.R. Am. J. Clin. Pathol. 20:1950;1059.
23. A.J. Duncan, Quality Control and Industrial Statistics, 5th ed., Irwin, Homewood, 1986.
24. T.P. Ryan, Statistical Method for Quality Improvement, Part II, Wiley & Sons, New York, 1989.
25. Thompson M., Howarth R.J. Analyst. 105:1980;1188.
26. G.B. Wetherhill, Sampling Inspections and Quality Control, 2nd ed., Chapman & Hall, London, 1977.
27. O.L. Davies, P.L. Goldsmith, Statistical Method in Research and Production, 4th ed. (revised), Oliver & Boyd for ICI, Edinburgh, 1972.
28. Thompson M., Howart R.J. Analyst. 101:1976;690.
29. M. Montagna, H. Muntau, A. Polettini, S. Facchetti, in: Proceedings of the International Conference and Workshop for Hair Analysis in Forensic Toxicology, Abu Dhabi, United Arab Emirates, November 1995, p. 370.
30. BIPM, IEC, IFCC, ISO, IUPAC, OIML, International Vocabulary of Basic and General Terms in Metrology, 2nd ed., ISO, Geneva, 1993.
31. Wu A.H.B. Ann. Clin. Lab. Sci. 25:1995;319.
32. ElSohly M.A., Jones A.B. J. Anal. Toxicol. 19:1995;450.
33. Mandatory Guidelines for Federal Workplace Drug Testing Programs; Final Guidelines; Notice, USA Federal Register, April 11, 53 (1988) 11978.
34. J.P. Dux, Handbook of Quality Assurance for the Analytical Chemistry Laboratory, Van Nostrand Rehinold Co., New York, 1986.
35. J.K. Taylor, Quality Assurance of Chemical Measurements, Lewis Publisher Inc., Chelsea, 1987.
36. T.A. Kubic, J.A. Buscaglia, in C.G.G. Aitken and D.A. Stoney (Eds.), The Use of Statistics in Forensic Science, Ellis Horwood, New York, 1990, p. 207.
37. J.O. Westgard, G.G. Klee, in: N.W. Tietz (Ed.), Textbook of Clinical Chemistry, Saunders, Philadelphia, 1986, p. 424.
38. Navy Drug Screening Laboratory Standard Operating Procedures (SOP) Manual, Naval Medical Command, US Navy, Washington, October 1, 1986.
39. Irving J. Clin. Chem. 34:1988;637.
40. J.P. Egan, Detection Theory and ROC Analysis, Academic Press, New York, 1977.
41. J.A. Swets, Evaluation of Diagnostic System: Methods from Signal Detection Theory, Academic Press, New York, 1982.
42. Lawson G.M. Clin. Chem. 40:1994;1219.
43. S.D. Ferrara, in: Proceedings of the European Military Conference on Drugs of Abuse: International Meeting on Assessment and Control of Drugs Abuse in Young Population and Mutual Relationship with Military Organizations in European Countries, Senger and Associates, Palo Alto, 1989.
44. Analytical Methods Committee, Analyst. 117:1992;97.
45. Welch M.J., Sniegoski L.T., Allgood C.C. Forensic Sci. Int. 63:1993;295.
46. Kintz P. Forensic Sci. Int. 70:1995;105.
47. Kintz P., Cirimele V. Forensic Sci. Int. 84:1997;151.
48. S.D. Ferrara, I.C. Dijkhuis, in: S.D. Ferrara (Ed.), Il Laboratorio di Farmacologia e Tossicologia Clinica, CG Ed. Med. Sci., Torino, 1989, p. 857.
49. Ferrara S.D. Forensic. Sci. Int. 63:1993;305.
50. I.C. Dijkhuis, B. Widdop, M. Moeller, in: Report of a Workshop on Proficiency Testing Programs for Psychoactive Substances, XXXV Meeting of The International Association of Forensic Toxicologists, Padova, Italy, August 1997.
51. H.J. Barth, in: G.A. Berman (Ed.), Testing Laboratory Performance: Evaluation and Accreditation, NBS Publication 591, National Institute of Standards and Technologies, Gaithersburg, 1980, p. 169.
52. Dijkhuis I.C. Lancet. ii:1982;1341.
53. Frings C.S., Battaglia D.J., White R.M. Clin. Chem. 35:1989;891.
54. US Department of Health, Education and Welfare, Proficiency Testing Summary Analysis: Toxicology of Drugs of Abuse, Technical reports, Atlanta, 1974-80.
55. Segura J., de la Torre R., Congost M., Cami J. Clin. Chem. 35:1989;879.
56. CBFT, Drugs of Abuse Proficiency Testing Summary Analysis, University of Padova, Technical Reports, Padova, 1982-96.
57. Wilson J.F., Smith B.L., Toseland P.A., Williams J., Burnett D., Hearst A.D., Watson I.D., Horn A.N. Ann. Clin. Biochem. 31:1994;335.
58. Schaller K.H., Angerer J., Lenhert G. Int. Arch. Occup. Environ. Health. 62:1991;537.
59. W. Horwitz, in: S.L. Inhorn (Ed.), Quality Assurance Practices for Health Laboratories, American Public Health Association, Washington, 1977, p. 616.
60. S.D. Ferrara, in: B. Kaempe (Ed.), Proceedings of the XXIX Meeting of The International Association of Forensic Toxicologists, MacKenzie, Copenhagen, Denmark, 1991, p. 69.
61. Hansen H.J., Caudill S.P., Boone J. J. Am. Med. Assoc. 253:1985;2382.
62. F.M. Garfield, Quality Assurance Principles for Analytical Laboratories, 5th ed., AOAC International, Arlington, 1991.
63. Colbert D.L. Br. J. Biomed. Sci. 51:1994;136.
64. Bosomworth M.P. Br. J. Biomed. Sci. 50:1993;150.
65. D'Nicuola J., Jones R., Levine B., Smith M.L. J. Anal. Toxicol. 16:1992;211.
66. Turner G.J., Colbert D.L., Chowdry B.Z. Ann. Clin. Biochem. 28:1991;588.
67. S.D. Ferrara, in: Proceedings of the International Conference: The European Drug Testing Environment: Emerging Issues and Challenges, Seville, Spain, November 1994, p. 39.
68. Westgard J.O., Seehafer J.J., Barry P.L. Clin. Chem. 40:1994;1909.
69. N.T. Crosby, J.A. Day, W.A. Hardcastle, D.G. Holcombe, R.D. Treble, F.E. Prichard, in: E.J. Newman (Ed.), Quality in the Analytical Chemistry Laboratory, Wiley & Sons, New York, 1995, p. 24.
70. J.O. Westgard, http://www.westgard.com/lesson14.htm, 1996.
71. Ferrara S.D., Tedeschi L. Ann. Ist. Super. Sanità 18:1982;727.
72. S.D. Ferrara, L. Tedeschi, in: E. Pistocchi, C. Baccini (Eds.), Proceedings of the National Congress, Il Laboratorio di Chimica Clinica e le Tossicodipendenze, Cesena, Italy, March 1982.
73. S.D. Ferrara, L. Tedeschi, in: S.D. Ferrara, I. Sunshine, A. Fuller (Eds.), Drugs of Abuse, Syva Publishing, Palo Alto, 1987, p. 41.